Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Health Econ. 2021 Aug 2;79:102512. doi: 10.1016/j.jhealeco.2021.102512

Table 6A.

Placebo regression estimates of the impact of the regime change on the fraction of NYS smokers who usually purchase premium-brand cigarettes—NYS-ATS

Regime change artificially imposed as of:
June 2004 June 2005 June 2006 June 2007 June 2010
Selected Regressors
Post 0.0206
(0.0390)		 −0.0085
(0.0205)		 −0.0150
(0.0319)		 0.0123
(0.454)		 −0.0626
(0.0409)
Distance −0.0767*
(0.0421)		 −0.0580*
(0.0307)		 −0.0668**
(0.0295)		 −0.0637**
(0.0286)		 −0.0665**
(0.0283)
Post*Distance 0.0346
(0.0323)		 0.0071
(0.0242)		 −0.0455
(0.0300)		 −0.0293
(0.0366)		 0.0480
(0.0583)
R2 0.1734 0.1725 0.1729 0.1726 0.1726
Sample Size (N) 6,989 6,989 6,989 6,989 6,989

Notes: The models used to generate the estimates above use only observations gathered prior to the regime change in June 2011, which accounts for the smaller sample size (N=6,989), relative to our main estimates in Table 2. Standard errors clustered at the county level are in parentheses

***

p<0.01,

**

p<0.05,

*

p<0.1. All placebo models contain the same covariates as the models that generated our main estimates as presented in Table 2.